Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PITCH-HF: Tadalafil in Heart Failure
NCT01910389Phase 3Terminated
- Sponsor
- Elevance Health
- Start
- Nov 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of tadalafil in heart failure (HF), pulmonary hypertension (PH), sponsored by Elevance Health. Started Nov 2013; status: terminated.
02
Drugs
tadalafil
03
Conditions
heart failure (HF)pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT01910389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01910389.